These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18288754)

  • 1. Drug for a while, polymer for life: Is it a good solution?
    Kastrati A
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):340-1. PubMed ID: 18288754
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions.
    Ruef J; Störger H; Schwarz F; Haase J
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):333-9. PubMed ID: 18288747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late target lesion revascularization following drug-eluting stents - looking back and forward to success.
    Moliterno DJ
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):304-5. PubMed ID: 18288752
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of drug-eluting stents in everyday clinical practice: can the results of randomised trials be achieved in the "real world"?
    Sionis DG
    Hellenic J Cardiol; 2005; 46(2):124-7. PubMed ID: 15847132
    [No Abstract]   [Full Text] [Related]  

  • 5. Forget Mars and venus, men and women are from the same planet after all.
    Parikh PB; Gruberg L
    J Invasive Cardiol; 2012 Jun; 24(6):261-2. PubMed ID: 22684378
    [No Abstract]   [Full Text] [Related]  

  • 6. A cagey proposition.
    Ho YD; Lee DP
    J Invasive Cardiol; 2008 Jan; 20(1):28. PubMed ID: 18174615
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The forgotten player of in-stent restenosis: endothelial dysfunction.
    Celik T; Iyisoy A; Kursaklioglu H; Celik M
    Int J Cardiol; 2008 Jun; 126(3):443-4. PubMed ID: 17466392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is... ".
    Navarese EP; Kubica J; Gurbel PA
    Int J Cardiol; 2011 Nov; 152(3):387. PubMed ID: 21911263
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to "Sirolimus or paclitaxel drug eluting stent in left main disease: the winner is...".
    Park KW; Kang SH; Kim HS
    Int J Cardiol; 2012 Jan; 154(2):192-3. PubMed ID: 22078987
    [No Abstract]   [Full Text] [Related]  

  • 11. IIb or not IIb? Toward a rational application of left main stenting.
    Uretsky BF
    J Am Coll Cardiol; 2010 Jun; 55(23):2553-5. PubMed ID: 20513594
    [No Abstract]   [Full Text] [Related]  

  • 12. A generation 2.5 drug-eluting stent?
    Ellis SG
    JACC Cardiovasc Interv; 2009 Oct; 2(10):986-8. PubMed ID: 19850259
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct versus predilatation drug-eluting stenting: a randomized clinical trial.
    Katritsis DG; Korovesis S; Karvouni E; Giazitzoglou E; Theodorou S; Kourlaba G; Panagiotakos D; Voridis E
    J Invasive Cardiol; 2006 Oct; 18(10):475-9. PubMed ID: 17235419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Vitrella G; Ferraro M; Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):436-9; discussion 440-1. PubMed ID: 15789401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
    Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 19. The artisan approach for stenting bifurcation lesions.
    Colombo A; Latib A
    JACC Cardiovasc Interv; 2010 Jan; 3(1):66-7. PubMed ID: 20129571
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular responses to drug eluting stents: importance of delayed healing.
    Finn AV; Nakazawa G; Joner M; Kolodgie FD; Mont EK; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1500-10. PubMed ID: 17510464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.